BioMarin Pharmaceutical's net profit under GAAP for 6 months of 2020 was $52,198 million, compared to a loss of $93,908 million the previous year. Revenue increased by 18.1% to $931.6 million compared to $788.5 million a year earlier.
BioMarin Pharmaceutical's net profit under GAAP for 6 months of 2020 was $52,198 million, compared to a loss of $93,908 million the previous year. Revenue increased by 18.1% to $931.6 million compared to $788.5 million a year earlier. 
investors.biomarin.com
English (US) 